Gregory Abel, MD, MPH, MFA
Gregory Abel, M.D.
Associate Professor of Medicine, Dana-Farber Cancer Institute

My research aims to apply health services methods to understand the experiences of patients with cancer and to answer questions about the effectiveness of cancer care. I am also interested in evaluating how intensive cancer therapy affects outcomes other than survival, such as quality of life and financial well-being. I primarily focus on the hematologic malignancies, studying the impact of these diseases and their treatment from diagnosis to the end of life. Specific interests have included the impact of direct-to-consumer advertising in cancer care, utility of surveillance imaging for patients with diffuse large B-cell lymphoma, effects of delays in diagnosis for blood cancers, and therapeutic changes and treatment disparities for patients with multiple myeloma. I have also been fortunate to receive a grant from the Leukemia and Lymphoma Society for a longitudinal study to compare the effectiveness of treatments for older patients with myelodysplastic syndromes (MDS). Another project aims to characterize the financial burden experienced by patients who undergo stem cell transplantation, and whether an increase in that burden is associated with compromised outcomes. Finally, I am interested in expanding and improving the tools available for outcomes research in hematologic oncology. For example, I am developing a new disease-specific measure of quality of life for patients with MDS (the QUALMS-1), and have created an MDS prognostic scoring system for use with the large SEER-Medicare dataset.

Publications View
US State Government Crisis Standards of Care Guidelines: Implications for Patients With Cancer.
Authors: Authors: Hantel A, Marron JM, Casey M, Kurtz S, Magnavita E, Abel GA.
JAMA Oncol
View full abstract on Pubmed
Consensus minimum hemoglobin level above which patients with myelodysplastic syndromes can safely forgo transfusions.
Authors: Authors: Tanasijevic AM, Revette A, Klepin HD, Zeidan A, Townsley D, DiNardo CD, Sebert M, DeZern AE, Stone RM, Magnavita ES, Chen R, Sekeres MA, Abel GA.
Leuk Lymphoma
View full abstract on Pubmed
Gait speed, survival, and recommended treatment intensity in older adults with blood cancer requiring treatment.
Authors: Authors: Hantel A, DuMontier C, Odejide OO, Luskin MR, Sperling AS, Hshieh T, Chen R, Soiffer R, Driver JA, Abel GA.
Cancer
View full abstract on Pubmed
Fit older adults with advanced myelodysplastic syndromes: who is most likely to benefit from transplant?
Authors: Authors: Abel GA, Kim HT, Hantel A, Steensma DP, Stone R, Habib A, Ho VT, Wadleigh M, El-Jawahri A, Alyea EP, DeAngelo DJ, Koreth J, Antin JH, Soiffer RJ, Cutler C.
Leukemia
View full abstract on Pubmed
American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults.
Authors: Authors: Sekeres MA, Guyatt G, Abel G, Alibhai S, Altman JK, Buckstein R, Choe H, Desai P, Erba H, Hourigan CS, LeBlanc TW, Litzow M, MacEachern J, Michaelis LC, Mukherjee S, O'Dwyer K, Rosko A, Stone R, Agarwal A, Colunga-Lozano LE, Chang Y, Hao Q, Brignardello-Petersen R.
Blood Adv
View full abstract on Pubmed
Defining Undertreatment and Overtreatment in Older Adults With Cancer: A Scoping Literature Review.
Authors: Authors: DuMontier C, Loh KP, Bain PA, Silliman RA, Hshieh T, Abel GA, Djulbegovic B, Driver JA, Dale W.
J Clin Oncol
View full abstract on Pubmed
Perspectives Regarding Hospice Services and Transfusion Access: Focus Groups With Blood Cancer Patients and Bereaved Caregivers.
Authors: Authors: Henckel C, Revette A, Huntington SF, Tulsky JA, Abel GA, Odejide OO.
J Pain Symptom Manage
View full abstract on Pubmed
An Action Plan for Environmentally Sustainable Cancer Care.
Authors: Authors: Hantel A, Abel GA.
JAMA Oncol
View full abstract on Pubmed
Patient-hematologist discordance in perceived chance of cure in hematologic malignancies: A multicenter study.
Authors: Authors: Loh KP, Xu H, Back A, Duberstein PR, Gupta Mohile S, Epstein R, McHugh C, Klepin HD, Abel G, Lee SJ, El-Jawahri A, LeBlanc TW.
Cancer
View full abstract on Pubmed
Goals of care discussions for patients with blood cancers: Association of person, place, and time with end-of-life care utilization.
Authors: Authors: Odejide OO, Uno H, Murillo A, Tulsky JA, Abel GA.
Cancer
View full abstract on Pubmed